Nothing Special   »   [go: up one dir, main page]

Testicular Tumours - Mashaal Saad

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 26

Testicular Tumors

Mashaal Saad 2016-038


TESTICULAR TUMOR

 1% of all Malignant tumor


 Affects young adults - 20 to 40 yrs - when Testosterone Fluctuations are
maximum
 90% to 95% of all Testicular tumors from germ cells
 99% of all Testicular tumors are malignant.
 Causes Psychological & Fertility Problems in young
 Cryptorchidism increases risk of developing testicular cancer
Classification

 Germinal Neoplasms : (90 - 95 %)


1. Seminomas - 40%
(a) Classic Typical Seminoma
(b) Anaplastic Seminoma
(c) Spermatocytic Seminoma
2. Embryonal Carcinoma - 20 - 25%
3. Teratoma - 25 - 35%
(a) Mature
(b) Immature
4. Choriocarcinoma - 1%
5. Yolk Sac tumor
Cont’d…

 B. Nongerminal Neoplasms : ( 5 to 10% )


1. Specialized gonadal stromal tumor
(a) Leydig cell tumor
(b) Other gonadal stromal tumor
Case

 A 40-year-old male presents with a painless left testicular mass and back
pain. The patient described a 2-month history of progressive scrotal
swelling.
 He also noted lower back pain that worsened with heavy lifting. The
patient denied a history of prior scrotal trauma or surgery.
 He also noted decreased appetite and an unintentional 20-pound weight
loss over the past 2 months.
 O/E:
 tachycardia, hypertension
 mild gynecomastia,
 a palpable mildly tender midline abdominal mass
 a firm enlarged non-tender left testicle measuring ~10 cm.
D/D for painless scrotal mass

 Hydrocele
 Spermatocele
 Hernia
 Varicocele
Investigations

 Aims
 Confirm the diagnosis
 Detect metastases
 Stage the disease

 Treat according to stage


Investigations

 Haematological – Hb%, Bl. urea/S. creatinine, LFT


 Tumour markers – AFP, HCG, LDH
 Scrotal Ultrasound – Usually homogenous, hypoechoic, intra testicular mass
 X-ray chest
 CT / MRI – abdomen
Scrotal Ultrasonography
Clinical Features

 History
 Solid testicular mass
 Gradual
 Trauma
 Testicular heaviness
 Back pain (retroperitoneal)
 Cough or dyspnea (pulmonary)
 Anorexia, nausea and vomiting (retroduodenal)
 Bone pain (skeletal)
 Lower extremity swelling (venacaval obstruction)
Clinical Features

 Painless, progressively enlarging testicular mass


 Para-aortic nodes at the level of L1/2
 Along lymphatic chain to thoracic duct to supraclavicular nodes

 Poorly differentiated tumors metastasize early


 Enlarged abdominal or cervical lymph nodes

 Cough, hemoptysis
Tumor Markers

TWO MAIN CLASSES


 Onco-fetal Substances : AFP & HCG
 Cellular Enzymes : LDH & PLAP
 AFP - Trophoblastic Cells

 HCG - Syncytiotrophoblastic Cells


Role of Tumor Markers

 Helps in Diagnosis - 80 to 85% of Testicular Tumours have Positive Markers


 Most of Non-Seminomas have raised markers
 Only 10 to 15% Non-Seminomas have normal marker level
 After Orchidectomy if Markers Elevated means Residual Disease or Stage II
or III Disease
 Elevation of Markers after lymphadenectomy means a STAGE III Disease
 Help determine tumor burden
Surgical Exploration

 Orchidectomy
 Inguinal incision
 Spermatic cord clamped
 Testis brought out
 Cord divided at internal inguinal ring
 Biopsy
TNM Classification

 T – primary tumor
 N – regional lymph nodes
 M – distant metastasis
 S – serum tumor markers
TNM Classification

 T – primary tumor
 TX: cannot be assessed
 T0: no evidence of primary tumor
 Tis: Intratubular cancer
 T1: limited to testis and epididymis, no vascular invasion
 T2: invades beyond tunica albuginea or has vascular invasion
 T3: invades spermatic cord
 T4: invades scrotum
TNM Classification

 N – regional lymph nodes


 NX: cannot be assessed
 N0: no regional lymph node metastases
 N1: lymph node metastases =/< 2cm and =/< 5 lymph nodes
 N2: metastasis in > 5 nodes, nodal mass > 2 cm and < 5cm
 N3: nodal mass > 5 cm
TNM Classification

 M – Distant metastasis
 MX: cannot be assessed
 M0: no distant metastasis
 M1: distant metastasis present
 M1a: nonregional nodal or pulmonary metastasis
 M1b: distant metastasis other than nonregional nodal or lung metastasis
TNM Classification

 S – Serum tumor markers


 SX: markers not available
 S0: Normal level
 S1: Lactate dehydrogenase (LDH) level < 1.5 times normal, human chorionic
gonadotropin (HCG) level < 5000 IU/L, alpha-fetoprotein (AFP) level < 1000
ng/mL
 S2: LDH 1.5–10 times normal; HCG level, 5000–50,000 IU/L; AFP level, 1000–10,000
ng/mL
 S3: LDH >10 times normal; HCG level >50,000 IU/L; AFP level >10,000 ng/mL
Stages of Spread of Testicular Tumors

 Stage I
 Tumor confined to testis
 Stage II
 Retroperitoneal lymph node involvement
 IIa nodes < 2cm
 IIb nodes 2 -5 cm
 IIc nodes > 5 cm
 Stage III
 Metastasis above diaphragm confined to lymph nodes
 Stage IV
 Extralymphatic metastases (usually lungs and liver)
Principles of Treatment

 Treatment should be aimed at one stage above the clinical stage


 Seminomas - Radio-Sensitive. Treat with Radiotherapy.
 Non-Seminomas are Radio-Resistant and best treated by Surgery
 Advanced Disease or Metastasis - Responds well to Chemotherapy
Treatment

1. Removal of the affected testis – usually performed as part of the


diagnostic process
2. No further treatment usually given if stage 1 disease (i.e. no metastases) but
careful surveillance with tumor markers and CT scans required
3. Radiotherapy – local irradiation alone for moderate abdominal lymph
node metastases in seminoma (stages IIa and IIb)
4. Chemotherapy with EP (etoposide and cisplatin) or BEP (bleomycin,
etoposide and cisplatin) – for all cases of metastatic teratoma and
metastatic seminoma beyond stage IIb
5. Debulking surgery for lymph nodes treated by chemotherapy
Management of Seminoma

 Stage I disease
 Orchidectomy +/- carboplatin based chemotherapy
 Stage IIa
 Radical radiotherapy to ipsilateral para-aortic and iliac nodes
 Stage IIb
 Radical radiotherapy or chemotherapy
 Etoposide and cisplatin (EP) or cisplatin, etoposide and bleomycin (PEB)
 Stages IIc and above
 Chemotherapy with etoposide and cisplatin (EP) or cisplatin, etoposide and
bleomycin (PEB)
Management

 Relapse within 1 year of orchidectomy without further treatment


 No role of curative radiotherapy

 Three options
1. Immediate chemotherapy
2. Retroperitoneal lymph node dissection
3. Surveillance and treatment

You might also like